| Abbreviations | Definitions |
| ABCG1 | ATP-binding cassette transporter G1 |
| ABTS | 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid |
| AE | Abelmoschus esculentus |
| AIF | Apoptosis-inducing factor |
| ALP | Alkaline phosphatase |
| ALT | Alanine transaminase |
| Akt | Protein kinase B |
| AMP | Adenosine 5′-monophosphate |
| AMPK | Adenosine monophosphate-activated protein kinase |
| AOPP | Advanced oxidation protein products |
| aP2 | Adipocyte protein 2 |
| ApoE | Apolipoprotein E |
| AST | Aspartate transaminase |
| AT-1 | Angiotensin II receptor-1 |
| ATPase | Adenosine 5′-TriPhosphatase |
| Bax | B-cell lymphoma protein 2 associated X |
| Bcl-2 | B-cell lymphoma 2 |
| BLA | Blood lactic acid |
| BMHC-imDCs | Rat bone marrow hematopoietic cells derived immature dendritic cells |
| BrdU | Bromodeoxyuridine |
| CA3 | Cornu Ammonis 3 |
| CAT | Catalase |
| CCl4 | Carbon tetrachloride |
| CD | Cluster of differentiation |
| CK | Creatine kinase |
| CYP7A1 | Cytochrome P450 7A1 |
| DCs cell | Dendritic cells |
| DPP-4 | Dipeptidyl peptidase-4 |
| DPPH | 2,2-Diphenyl-1-picrylhydrazyl |
| EMT | Epithelial-mesenchymal transition |
| FAS | Fatty acid synthase |
| FGF-2 | Fibroblast growth factor-2 |
| FRAP | Ferric reducing ability of plasma |
| FST | Forced swimming test |
| GAG | Glycosaminoglycans |
| Gal-3 | Galectin-3 |
| GGT | Gamma glutamyltransferase |
| GLP-1R | Glucagon like peptide-1 receptor |
| GOT | Glutamate oxaloacetate transaminase |
| GPT | Glutamate pyruvate transaminase |
| GPx | Glutathione peroxidase |
| GR | Glutathione reductase |
| GSH | Glutathione |
| GSH-Px | Glutathione peroxidase |
| GSK-3β | Glycogen synthase kinase-3 beta |
| HbA1c | Glycated hemoglobin |
| HDF | Human dermal fibroblast adult cell |
| HDL | High-density lipoprotein |
| HDLC | High-density lipoprotein-cholesterol |
| HFE | Hemochromatosis protein |
| HG | Hepatic glycogen |
| HO-1 | hemeoxygenase-1 |
| HOMA-IR | Homeostasis model assessment of insulin resistance |
| ICAM-1 | Intercellular adhesion molecule-1 |
| IFN-γ | Interferon gamma |
| IL-6 | Interleukin-6 |
| IBD | Inflammatory bowel disease |
| iNOS | Inducible nitric oxide synthase |
| LDH | Lactate dehydrogenase |
| LDL | Low-density lipoprotein |
| LDL-c | Low-density lipoprotein-cholesterol |
| LOX-1 | Lectin-like oxidized low-density lipoprotein receptor 1 |
| LPL | Lipoprotein lipase |
| LXR | Liver X receptors |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MDA | Malondialdehyde |
| MG | Muscle glycogen |
| MHC | Major histocompatibility complex |
| MIC | Minimum inhibitory concentration |
| MPO | Myeloperoxidase |
| mRNA | Messenger ribonucleic acid |
| mTOR | Mammalian target of rapamycin |
| NAFLD | Non-alcoholic fatty liver disease |
| NF-κB | Nuclear transcription factor-κB |
| NLRP3 | Nucleotide-binding domain and leucine-rich repeat containing family Pyrin domain containing 3 |
| NMDA | N-methyl-D-aspartate |
| NO | Nitric oxide |
| Non-HDLC | Non-high-density lipoprotein-cholesterol |
| NR | NMDA-receptor |
| Nrf2 | Nuclear factor E2-related factor-2 |
| OA | Oleic acid |
| Ox-LDL | Oxidized low-density lipoprotein |
| PCNA | Proliferating cell nuclear antigen |
| PI3K | Phosphoinositide 3-kinase |
| PMRS | Plasma membrane redox system |
| PPAR | Peroxisome proliferator-activated receptor |
| PTP1B | Protein tyrosine phosphatase 1B |
| RG-I | Rhamnogalacturonan-I |
| SDH | Succinate dehydrogenase |
| SOD | Superoxide dismutase |
| SREBP1c | Sterol regulatory element-binding protein 1c |
| SUN | Serum urea nitrogen |
| TBARS | Thiobarbituric acid reactive substances |
| TC | Total cholesterol |
| TG | Triglyceride |
| TGF-β1 | Transforming growth factor β1 |
| TH1 | Type 1 T helper |
| TMJ | Temporomandibular joint |
| TNF-α | Tumor necrosis factor alpha |
| TLR4 | Toll-like receptor 4 |
| TUNEL | Terminal deoxynucleotidyl transferase dUTP nick end labeling |
| UCP2 | Uncoupling protein 2 |
| UV-B | Ultraviolet B radiation |
| VLDL | Very-low-density lipoprotein |